Skip to content

A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of T7-010 in Healthy Participants.

Status
Suspended
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518440-20-00
Acronym
T7-010-01
Enrollment
32
Registered
2025-05-27
Start date
2025-09-16
Completion date
Unknown
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Diseases (Healthy Volunteers)

Interventions

None listed

Sponsors

T7 Therapeutics Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Hungary

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026